Visual Results of the Acrysof IQ Vivity Toric Extended Vision Intraocular Lens
Recruiting in Palo Alto (17 mi)
GD
Overseen byGeorges Durr, MD, FRCSC
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
No Placebo Group
Trial Summary
What is the purpose of this trial?
This trial is studying a special lens used in cataract surgery that helps people see better at different distances and corrects astigmatism. These lenses have become the preferred choice for surgeons to correct vision issues during cataract surgery. The lens is designed to stay stable in the eye, which is important for clear vision. The goal is to reduce the need for glasses and improve quality of life for patients with significant astigmatism.
Research Team
GD
Georges Durr, MD, FRCSC
Principal Investigator
Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria
Inclusion Criteria
Patients undergoing uncomplicated cataract surgery with intraocular lens implantation
Patients motivated by a greater degree of spectacle independence
Patients possessing with-the-rule astigmatism of ≥ 0.75 diopters (D) or against-the-rule astigmatism of ≥ 0.50 D
See 3 more
Treatment Details
Interventions
- Acrysof IQ Vivity Toric Extended Vision Intraocular Lens (Intraocular Lens)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Acrysof IQ Vivity Toric Extended Vision Intraocular Lens ImplantationExperimental Treatment1 Intervention
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Centre hospitalier de l'Université de Montréal (CHUM)Montreal, Canada
Loading ...
Who Is Running the Clinical Trial?
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor
Trials
389
Patients Recruited
143,000+